Roseanne Tom
National Research Council
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Roseanne Tom.
Biotechnology Progress | 2009
Chun Fang Shen; Robert Voyer; Roseanne Tom; Amine Kamen
Adenovirus production is currently operated at low cell density because infection at high cell densities still results in reduced cell‐specific productivity. To better understand nutrient limitation and inhibitory metabolites causing the reduction of specific yields at high cell densities, adenovirus production in HEK 293 cultures using NSFM 13 and CD 293 media were evaluated. For cultures using NSFM 13 medium, the cell‐specific productivity decreased from 3,400 to 150 vp/cell (or 96% reduction) when the cell density at infection was increased from 1 to 3 × 106 cells/mL. In comparison, only 50% of reduction in the cell‐specific productivity was observed under the same conditions for cultures using CD 293 medium. The effect of medium osmolality was found critical on viral production. Media were adjusted to an optimal osmolality of 290 mOsm/kg to facilitate comparison. Amino acids were not critical limiting factors. Potential limiting nutrients including vitamins, energy metabolites, bases and nucleotides, or inhibitory metabolites (lactate and ammonia) were supplemented to infected cultures to further investigate their effect on the adenovirus production. Accumulation of lactate and ammonia in a culture infected at 3 × 106 cells/mL contributed to about 20% reduction of the adenovirus production yield, whereas nutrient limitation appeared primarily responsible for the decline in the viral production when NSFM 13 medium was used. Overall, the results indicate that multiple factors contribute to limiting the specific production yield at cell densities beyond 1 × 106 cells/mL and underline the need to further investigate and develop media for better adenoviral vector productions.
Enzyme and Microbial Technology | 1993
Keith B. Male; John H. T. Luong; Roseanne Tom; S. Mercille
Abstract A flow injection analysis (FIA) biosensor system has been developed for determining glutamine in insect cell and in murine hybridoma cell cultures. Glutamate oxidase and glutaminase, respectively, were covalently immobilized onto porous aminopropyl glass beads to form an immobilized enzyme column. The hydrogen peroxide produced by the enzyme reactions was detected by an amperometric electrode (platinum vs. silver/silver chloride) posied at +0.7 V . Among several anion exchange resins tested, endogenous glutamate was completely adsorbed onto acetate anion exchange resins. Such an ion exchanger also effectively adsorbed aspartic acid, uric acid, ascorbic acid, and acetaminophen. The FIA biosensor was linear up to 1 m m glutamine, with a lower detection limit of 10 μ m , and possessed good reproducibility (relative error of ± 1.2%). Each analysis could be performed in 3.5 min including sampling and washing with a corresponding throughput of 17 h −1 . The anion exchange column could be operated continuously for 12 h for 200 analyses with diluted cell culture. The immobilized enzyme column was stable for at least 500 repeated analyses without significant loss of activity. When the biosensor system was applied to glutamine measurement in insect cell and mammalian cell cultures, the results obtained compared well with those of HPLC.
CSH Protocols | 2008
Roseanne Tom; Louis Bisson; Yves Durocher
INTRODUCTIONFast and efficient production of recombinant proteins (r-proteins) remains a major challenge for the academic and biopharmaceutical communities. Such proteins often need to be as pure as possible before any characterization study can begin. Although many types of protein tag are available, histidine is the most popular. Although small-scale immobilized metal-affinity column (IMAC) purification of such proteins (e.g., <500 mL of culture medium) can easily be achieved using gravity chromatography columns, larger volumes can be processed with the aid of automated chromatography systems. This protocol describes an IMAC purification technique for secreted proteins using a cobalt-loaded resin. Preliminary small-scale trials using this technique can be used to determine the production scale that will be needed to provide enough pure material for a given study.
Environmental Science & Technology | 2010
Keith B. Male; Roseanne Tom; Yves Durocher; Charles W. Greer; John H. T. Luong
In an effort to develop a noninvasive method for assessment of cyanobacterial toxins in drinking water, plausible cytotoxicity/inhibition of microcystin-LR and cylindrospermopsin was evaluated by cell-substrate impedance sensing (ECIS) using three different cell lines. Sf9 insect cells were attached to concanavalin A coated gold electrodes, whereas Chinese hamster ovary (CHO) and human embryo kidney (HEK) cells were attached to a fibronectin or laminin coated gold surface. Cytotoxic or inhibitory effects were dependent upon the cell line and the extracellular matrix (ECM) coating. Neither toxin exhibited any appreciable effect on the insect cells. In contrast, cytotoxicity of cylindrospermopsin on CHO cells was attested by both ECIS and viability tests. The half-inhibition concentration (ECIS50) of cylindrospermopsin for CHO cells was approximately 2 microg/mL (ppm) after 20 h of exposure and 4 microg/mL (ppm) after 30 h of exposure for a laminin or fibronectin coated surface. ECIS confirmed no significant effect of cylindrospermopsin on HEK cells. Microcystin-LR was also tested with CHO cells, resulting in an ECIS50 value of approximately 12 microg/mL (ppm) after 25 h of exposure for a laminin coated gold surface. The effect of microcystin-LR on CHO cells probed by ECIS was inhibitory rather than cytotoxic, as confirmed by cell viability assays.
Methods | 2011
Céline Raymond; Roseanne Tom; Sylvie Perret; Pascal Moussouami; Denis L’Abbé; Gilles St-Laurent; Yves Durocher
CSH Protocols | 2008
Roseanne Tom; Louis Bisson; Yves Durocher
Journal of Virological Methods | 2008
Angélica Meneses-Acosta; Edwige Dormond; Danielle Jacob; Roseanne Tom; Alice Bernier; Sylvie Perret; Gilles St-Laurent; Yves Durocher; Rénald Gilbert; Amine Kamen
CSH Protocols | 2008
Roseanne Tom; Louis Bisson; Yves Durocher
Molecular Cancer Therapeutics | 2012
John Zwaagstra; Traian Sulea; Jason Baardsnes; Anne E.G. Lenferink; Cathy Collins; Christiane Cantin; Beatrice Paul-Roc; Suzanne Grothe; Sazzad Hossain; Louis-Philippe Richer; Denis L'Abbé; Roseanne Tom; Brian Cass; Yves Durocher; Maureen O'Connor-McCourt
CSH Protocols | 2008
Roseanne Tom; Louis Bisson; Yves Durocher